Combunox

This page contains recent news articles, when available, and an overview of Combunox but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Combunox
(when available)

Pharmacology and use:
Oxycodone, a semisynthetic opiate agonist derived from the opioid alkaloid, thebaine, is similar to other phenanthrene derivatives such as hydrocodone and morphine. Oxycodone is available in combination with aspirin or acetaminophen to control pain and restless leg and Tourette syndromes. For the treatment of diarrhoea, pulmonary oedema; For the relief of moderate to moderately severe pain

Mechanism Of Action:
Oxycodone acts as a weak agonist at OP1, OP2, and OP3 opiate receptors within the central nervous system (CNS). Oxycodone primarily affects OP3 receptors, which are coupled with G-protein receptors and function as modulators, both positive and negative, of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine, and noradrenaline is inhibited. Opioids such as Oxycodone also inhibit the release of vasopressin, somatostatin, insulin, and glucagon. Opioids close N-type voltage-operated calcium channels (OP2-receptor agonist) and open calcium-dependent inwardly rectifying potassium channels (OP3 and OP1 receptor agonist). This results in hyperpolarization and reduced neuronal excitability.

News Articles on Oxycodone

Barr gets FDA nod for generic Combunox tablets  -  Nov 29, 2007
Nov 29 (Reuters) - Barr Pharmaceuticals Inc BRL.N said it received final approval from US health regulators to market a generic version of Forest ... Reuters

New COMBUNOX(TM) (Oxycodone HCl and Ibuprofen) Tablets (CII) Now …  -  Mar 21, 2005
NEW YORK, March 21 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. announced today that COMBUNOX(TM) (Oxycodone HCl and Ibuprofen) Tablets (CII) are now ... RedOrbit

Forest Beats, Guides In Line  -  Jan 18, 2005
Solomon added that Forest expects to start marketing Combunox in March, which was recently approved by the Food and Drug Administration for treating acute ... TheStreet.com - TheStreet.com (subscription)

First-Time Generic Approvals: Combunox, Dilantin, Antizol  -  Dec 28, 2007
December 28, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for oxycodone hydrochloride and ibuprofen tablets ... Medscape

Press Release: New COMBUNOX(TM) (Oxycodone HCl and Ibuprofen) …  -  Mar 21, 2005
New COMBUNOX(TM) (Oxycodone HCl and Ibuprofen) Tablets (CII) Now Available for the Short-Term Treatment of Acute, Moderate to Severe Pain. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research

Watson Receives FDA Approval For Generic Combunox(R).  -  Nov 27, 2007
CORONA, Calif., Nov. 27 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that it has ... Free with registration - PR Newswire - AccessMyLibrary.com

Pain Medicine; US FDA approves Combunox for the short-term treatment ...  -  Jan 2, 2005
2005 JAN 2 - (NewsRx.com & NewsRx.net) -- Forest Laboratories, Inc., (FRX) announced that Combunox (Oxycodone HCl and Ibuprofen) Tablets (CII), according to ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones

Oxycodone hydrochloride and ibuprofen tablets (CII).(NEW GENERICS)( …  -  Jan 14, 2008
This approval offers a generic equivalent to Combunox, from Forest Laboratories. The product is indicated for the short-term management of acute, ... Free with registration - Drug Topics - AccessMyLibrary.com

Forest Labs debuts Combunox in USA.(Brief Article)  -  Mar 28, 2005
Forest Laboratories has announced that Combunox (oxycodone HCl and ibuprofen) tablets are now available to US physicians and pharmacies nationwide. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com

… Receives FDA Approval For Generic Combunox(R). - PR Newswire | …  -  Nov 27, 2007
Watson Receives FDA Approval For Generic Combunox(R). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

… Release: Barr Receives Approval for Generic Combunox(R) Tablets,...  -  Nov 29, 2007
Barr Receives Approval for Generic Combunox(R) Tablets, 5mg/400mg. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Combunox[TM] (oxycodone hydrochloride/ibuprofen): Forest Laboratories...  -  Feb 1, 2005
Combunox, the first and only fixed-dose combination of the opioid oxycodone (5 mg) and the NSAID ibuprofen (400 mg), has been approved for the short-term ... $4.95 - Clinician Reviews - ECNext

Event Brief of Q2 2006 Forest Laboratories, Inc. Earnings Conference...  -  Oct 1, 2005
In terms of Combunox, we did launch a new program, sort of a trial type program in I guess it was September and -- the latter part of September. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Q1 2006 Forest Laboratories, Inc. Earnings Conference Call - Final.  -  Jul 19, 2005
Also during the quarter, Campral, our product for alcohol addiction, continued to perform to our expectations, while Combunox, approved for the short-term ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Forest Labs' sales hit by Celexa competition.(Brief Article)  -  May 2, 2005
Campral (acamprosate calcium), for the maintenance of abstinence from alcohol), and Combunox (oxycodone and ibuprofen), for acute-to-moderate pain, ... $4.95 - Pharma Marketletter - ECNext

Forest Laboratories, Inc. Combination tablets now available for short...  -  Apr 20, 2005
COMBUNOX was approved by the US Food and Drug Administration (FDA) on ... COMBUNOX is the first and only product to combine 5 mg of oxycodone HCl and 400 mg ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones

Pain Management; Combination tablets now available for short-term …  -  Apr 18, 2005
COMBUNOX was approved by the US Food and Drug Administration (FDA) on ... COMBUNOX is the first and only product to combine 5 mg of oxycodone HCl and 400 mg ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones

Article: asktheDoc.(Features) - Daily Record (Glasgow, Scotland) | …  -  Jan 31, 2006
Pharmacology Update Oxycodone and Ibuprofen Tablets (Combunox.sup.TM) By William T. Elliott, MD, ... COMBUNOX was approved by the U.S. Food and Drug ... ... Pay-Per-View - Daily Record - HighBeam Research

Floundering fortunes: few specialty journal markets emerged from last...  -  May 1, 2006
Forest's Combunox was 8th and Wyeth's new antibiotic, Tygacil IV, ranked 10th. Once again, spending in ophthalmology journals during 2005 grew at a faster ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

Deep freeze: for medical/surgical journals, 2005 was another long,...  -  Apr 1, 2006
Combunox, a new oxycodone HCl and ibuprofen combination from Forest, was 4th, and Lunesta, Sepracor's new non-barbiturate sedative, ranked 5th. ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

Forest Labs Outlook Disappoints  -  Oct 6, 2005
Goodman added that Forest has lowered its revenue forecast for Combunox, saying sales trends are "significantly under plan" and could fall $75 million below ... TheStreet.com - TheStreet.com (subscription)

Forest Labs 3Q profit drops 25 percent on collaboration payment  -  Jan 17, 2006
Forest Labs also said it will stop promoting Combunox, a pain drug, ... Steven doesn't view the announcement as a major issue since Combunox was never ... $2.95 - Associated Press Archive - NewsBank

On the level: medical/surgical journal publishers must wait a little...  -  Apr 1, 2007
Products missing from the top 25 include two from Forest--Combunox and Campral-and two from Merck/Schering Plough--Vytorin and Zetia. ... Free with registration - Medical Marketing & Media - AccessMyLibrary.com

RadioPharma Partners acquires CIS bio International SA from Schering ...  -  May 5, 2006
Condition Treated Trial Phase Source Partner Combunox (oxycodone and ibuprofen) Pain…Last Updated #/#/#### Partnering Details #/#/#### -- British… ... Pay-Per-View - deals - Alacra Store

Movers: Citigroup, Staples, Activision, Bidz.com  -  Nov 27, 2007
...its Abbreviated New Drug Application of Oxycodone Hydrochloride and Ibuprofen Tablets, which is the equivalent to FRX's Combunox, in 5mg/400mg strength. ... BusinessWeek

Forest Laboratories Reports Earnings Per Share of .59 for Q2'06 -...  -  Oct 18, 2005
Combunox(TM) (Oxycodone HCl and Ibuprofen), an opioid and NSAID combination indicated for the short-term management of acute, moderate to severe pain. ... RedOrbit

Forest Makes With Fourth Quarter and Full Year Results  -  Apr 19, 2005
Campral and Combunox will reduce earnings in fiscal 2006 during their launch phase but should contribute to earnings in the future. ... WebProNews

Forest Laboratories, Inc. at Smith Barney Citigroup Healthcare …  -  Mar 29, 2005
In the first prong we have in the market now 5 products; 3 of them key products for us Combunox and Campral recent product additions, smaller relative to ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Endo Announces Executive Appointment  -  Apr 11, 2008
...an SSRI antidepressant, Namenda®, an NMDA receptor antagonist for the treatment of moderate to severe Alzheimer's Disease and Combunox(TM), ... Web Services Journal - Web Services Journal

Learn about Oxycodone from Consumer Reports Health.  -  Jan 1, 2008
...aspirin (Endodan, Percodan, Roxiprin, others); and ibuprofen (Combunox). This monograph only includes information about the use of oxycodone alone. ... consumerreports.org

Factiva Search  -  Jan 1, 2005
Pain Medicine; U.S. FDA approves Combunox for the short-term treatment of acute pain. 01 January, 2005 Obesity, Fitness & Wellness Week ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones

Forest Laboratories, Inc. Names Ivan Gergel, MD, Senior Vice-President...  -  May 19, 2005
...an SSRI antidepressant, Namenda(R), an NMDA receptor antagonist for the treatment of moderate to severe Alzheimer's Disease and Combunox(TM), ... $4.95 - PR Newswire - ECNext

Forest Laboratories.(Pipeline) | Article from Medical Marketing &...  -  Jan 1, 2005
...find Medical Marketing & Media articles. Combunox (Oxycodone HCI and Ibuprofen) has been approved by the FDA for moderate to severe pain typically exp... Pay-Per-View - Medical Marketing & Media - HighBeam Research

First-half frailty: talk of an upturn in second-half ad revenues is...  -  Nov 1, 2005
Lilly's Cymbalta took the number one spot followed by Combunox (2nd) and Tarceva (3rd). Other new entries include Invirase 500 (7th), itraconazole (8th), ... $9.94 - Medical Marketing & Media - Alacra Store

Press Release: Forest Laboratories, Inc. Names Ivan Gergel, MD,...  -  May 19, 2005
...an SSRI antidepressant, Namenda(R), an NMDA receptor antagonist for the treatment of moderate to severe Alzheimer's Disease and Combunox(TM), ... Pay-Per-View - PR Newswire - HighBeam Research

Long Island Business News : LI-based Forest Laboratories marketing …  -  Mar 25, 2005
Forest said it's marketing Combunox, which combine Oxycodone HCl and Ibuprofen ... Combunox was approved last year by the U.S. Food and Drug Administration. ... $2.95 - Long Island Business News - NewsBank

What Is the Maximum Safe Dose of Opioids?  -  Feb 21, 2008
...[1,2] When using combination opioid products containing acetaminophen, aspirin, or ibuprofen (such as Percocet, Percodan, and Combunox), the dose limiting ... Medscape

Mylan Laboratories and Forest Laboratories Announce Nebivolol …  -  Jan 11, 2006
Combunox(TM) (Oxycodone HCl and Ibuprofen), an opioid and NSAID combination indicated for the short-term management of acute, moderate to severe pain. ... Free with registration - PR Newswire - AccessMyLibrary.com

Trade Alert for Forest Laboratories Inc.  -  May 23, 2007
Campral for the maintenance of alcohol abstinence; and Combunox for the short-term management of acute, and moderate-to-severe pain. ... Free with registration - M2 Presswire - AccessMyLibrary.com

Replidyne and Forest Laboratories Announce FDA Acceptance for …  -  Feb 23, 2006
...alcohol dependence who are abstinent at treatment initiation in combination with psychosocial support; and Combunox (TM) (oxycodone HCl and ibuprofen), ... RedOrbit

Harmony Information Sys Inc acquires Synergy Software Tech Inc from …  -  Feb 11, 2008
Products: Combunox (Oxycodone/Ibuprofen) Hi-Tech Pharmacal Co. ( HITK ) Products: APAP…Ranger/Quantum Ranger Boston Scientific Synergy SCIMED Rebel ... Pay-Per-View - deals - Alacra Store

Watson两ç§?仿制镇痛è?¯èŽ·FDA批准  -  Nov 27, 2007
...这两��片是Forest Laboratories Inc.(FRX)生产的镇痛�Combunox的仿制版本,�者 截至9月份在美国的年度销售�大约为400万美元。 新浪声明:本版文章内容纯属作者个人 ... 新浪网

Forest Laboratories Signs Grants Manager Agreement With Fast Track …  -  Apr 19, 2006
Combunox(TM) (Oxycodone HCl and Ibuprofen), an opioid and NSAID combination indicated for the short-term management of acute, moderate to severe pain. ... RedOrbit

Assess the Financial Performance of Forest Laboratories within the …  -  Nov 9, 2006
Chapter 6. Appendix List of TablesList of Figures Key products and competitors- Lexapro - Namenda - milnacipran - Combunox - Orapem - nebivolol ... Free with registration - M2 Presswire - AccessMyLibrary.com

Research and Markets: Assess the Financial Performance of Forest …  -  Nov 9, 2006
Lexapro - Namenda - milnacipran - Combunox - Orapem - nebivolol For more information visit http://www.researchandmarkets.com/reports/c44883 ... Free with registration - Business Wire - AccessMyLibrary.com

Event Brief of Q1 2008 Forest Laboratories, Inc. Earnings Conference...  -  Jul 17, 2007
Combunox, $700000. 6. Esgic, $1m. 7. Europe, $16.5m. 8. Generics, $3.1m. 9. Infasurf, $3.2m. 10. Lorcet, $2.6m. 11. Monurol, $300000. 12. Tessalon, $4.6m. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Forest Laboratories earnings expected lower.  -  Jan 12, 2006
Sales of its pain reliever Combunox, a combination of generic Oxycontin and ibuprofen, also have been lower than expected. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com

Article: Watson gets approval.(Generic Drugs)(Brief article) - Chain...  -  Dec 17, 2007
Watson Pharmaceuticals Inc. has received FDA approval for a generic equivalent to Forest Laboratories Inc.'s Combunox. The product ... ... Pay-Per-View - Chain Drug Review - HighBeam Research

Forest Laboratories, Inc. Reports Q4'06 Diluted Earnings Per Share of...  -  Apr 25, 2006
The year-ago period included initial launch spending in support of Campral(R)*, a product to treat alcohol dependence and Combunox(R), a product indicated ... $4.95 - PR Newswire - ECNext

On the level: medical/surgical journal publishers must wait a little...  -  Apr 1, 2007
Forest dropped from 2nd to 4th following a reduction in ad outlays for Namenda, Campral and Combunox while Lilly slipped from 4th to 5th following an 18% ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

First New Treatment for Alcoholism in Ten Years, Now Available...  -  Jan 11, 2005
...with psychosocial support; Combunox(TM) (Oxycodone HCl and Ibuprofen) an opioid and NSAID combination indicated for the short-term management of acute, ... RedOrbit

Replidyne and Forest Laboratories Announce Faropenem Medoxomil …  -  Feb 13, 2006
...alcohol dependence who are abstinent at treatment initiation in combination with psychosocial support; and Combunox(TM) (oxycodone HCl and ibuprofen), ... $4.95 - PR Newswire - ECNext

Mixed fortunes: laboratory journals posted a 7% hike, while five of...  -  Nov 1, 2007
Among the six Pfizer products that ... from 2nd to 4th following a reduction in ad outlays for Namenda, Campral and Combunox while . ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Gedeon Richter and Forest Laboratories Expand Relationship with Two …  -  Nov 28, 2005
Combunox(TM) (Oxycodone HCl and Ibuprofen), an opioid and NSAID combination indicated for the short-term management of acute, moderate to severe pain. ... Free with registration - PR Newswire - AccessMyLibrary.com

Forest Laboratories, Inc. Reports Fiscal First Quarter 2006 Results.  -  Jul 19, 2005
Combunox(TM) (Oxycodone HCl and Ibuprofen), an opioid and NSAID combination indicated for the short-term management of acute, moderate to severe pain. ... $4.95 - PR Newswire - ECNext

Only 34% of US General Public Recognize Alcoholism as a Disease  -  Oct 3, 2005
COMBUNOX(TM) (Oxycodone HCl and Ibuprofen) an opioid and NSAID combination indicated for the short-term management of acute, moderate to severe pain. Medical News Today - Medical News Today (press release)

Some new and not-so-new drugs that are heavily promoted.(Brief...  -  Feb 1, 2006
Combunox is advertised by Forest Pharmaceuticals as though it were a new drug. Actually, it is a combination of two old drugs: the semi-synthetic opioid ... $4.95 - HealthFacts - ECNext

Watson gets approval.  -  Dec 17, 2007
Watson Pharmaceuticals Inc. has received FDA approval for a generic equivalent to Forest Laboratories Inc.'s Combunox. The product is indicated for the ... $9.94 - Chain Drug Review - Alacra Store

Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce...  -  Sep 28, 2005
...and Combunox(TM)(Oxycodone HCl and Ibuprofen), an opioid and NSAID combination indicated for the short-term management of acute, moderate to severe pain ... $4.95 - PR Newswire - ECNext

Forest Laboratories Announces FDA Decision on Supplemental New …  -  Jul 25, 2005
Combunox(TM) (Oxycodone HCl and Ibuprofen), an opioid and NSAID combination indicated for the short-term management of acute, moderate to severe pain. ... $4.95 - PR Newswire - ECNext

Forest Laboratories, Inc. and Cypress Bioscience, Inc. to Commence …  -  Jan 5, 2006
...and Combunox(TM)(Oxycodone HCl and Ibuprofen), an opioid and NSAID combination indicated for the short-term management of acute, moderate to severe pain ... $4.95 - PR Newswire - ECNext

Forest Laboratories to Exceed Fiscal 2005 Third Quarter Mean Earnings...  -  Jan 4, 2005
...with psychosocial support; Combunox(TM) (Oxycodone HCl and Ibuprofen) an opioid and NSAID combination indicated for the short-term management of acute, ... $4.95 - PR Newswire - ECNext

Forest Laboratories, Inc. to Continue Clinical Development of …  -  Jul 14, 2005
Combunox(TM) (Oxycodone HCl and Ibuprofen), an opioid and NSAID combination indicated for the short-term management of acute, moderate to severe pain. ... $4.95 - PR Newswire - ECNext

Forest Laboratories Starts Confirmatory Study of Desmoteplase A Novel...  -  Feb 9, 2005
...with psychosocial support; Combunox(TM) (Oxycodone HCl and Ibuprofen) an opioid and NSAID combination indicated for the short-term management of acute, ... $4.95 - PR Newswire - ECNext

New Survey Results from the Community Anti-Drug Coalitions of America...  -  Sep 29, 2005
COMBUNOX(TM) (Oxycodone HCl and Ibuprofen) an opioid and NSAID combination indicated for the short-term management of acute, moderate to severe pain. $4.95 - PR Newswire - ECNext

Forest Laboratories, Inc. Announces New Share Repurchase Program.  -  May 10, 2005
Combunox(TM) (Oxycodone HCl and Ibuprofen), an opioid and NSAID combination indicated for the short-term management of acute, moderate to severe pain. ... $4.95 - PR Newswire - ECNext

Press Release: Forest Laboratories, Inc. Reports Q4'06 Diluted...  -  Apr 25, 2006
The year-ago period included initial launch spending in support of Campral(R)*, a product to treat alcohol dependence and Combunox(R), a product indicated ... Pay-Per-View - PR Newswire - HighBeam Research

Combination oxycodone and ibuprofen.  -  Feb 1, 2005
Combination oxycodone and ibuprofen (Combunox, Forest) was approved for the short-term management of acute moderate-to-severe pain. ... $9.94 - Formulary - Alacra Store

Oral Solution Formulation of Namenda(R), the Only FDA-Approved Oral …  -  Aug 18, 2005
...and Combunox(TM)(Oxycodone HCl and Ibuprofen), an opioid and NSAID combination indicated for the short-term management of acute, moderate to severe pain ... $4.95 - PR Newswire - ECNext

Press Release: Forest Laboratories Announces Court Sets New Trial …  -  Apr 28, 2005
Combunox(TM) (Oxycodone HCl and Ibuprofen), an opioid and NSAID combination indicated for the short-term management of acute, moderate to severe pain. ... Pay-Per-View - PR Newswire - HighBeam Research

New drugs.  -  Apr 18, 2005
Approved in late 2004, Combunox (oxycodone HCl and ibuprofen) tablets, 5 mg/400 mg (CII), are now available from St. Louis-based Forest Laboratories, ... $9.94 - Drug Topics - Alacra Store

Merger and Acquisition Scenario  -  Mar 11, 2006
The Company's products include Lexapro, Celexa, Namenda, Benicar, Campral, Combunox, RGH-188, GRC 3886, Desmoteplase, CCR1 Antagonists, Milnacipran, ... $250.00 - Revere Reports - Revere

Article: Forest Laboratories, Inc.(theInvestmentSection) - Research |...  -  Sep 1, 2005
Combunox[TM] indicated for the short-term management of acute, moderate to severe pain. Read all of this article with a FREE trial ... Pay-Per-View - Research - HighBeam Research

Forest Laboratories, Inc. Announces Launch of Clinical Trial Registry...  -  Feb 8, 2005
...with psychosocial support; Combunox(TM) (Oxycodone HCl and Ibuprofen) an opioid and NSAID combination indicated for the short-term management of acute, ... $4.95 - PR Newswire - ECNext

Forest Laboratories Announces Court Sets New Trial Date for Lexapro …  -  Apr 28, 2005
Combunox(TM) (Oxycodone HCl and Ibuprofen), an opioid and NSAID combination indicated for the short-term management of acute, moderate to severe pain. ... $4.95 - PR Newswire - ECNext

Research and Markets: Assess the Financial Performance of Forest …  -  Nov 9, 2006
Lexapro - Namenda - milnacipran - Combunox - Orapem - nebivolol For more information visit http://www.researchandmarkets.com/reports/c44883 ... $4.95 - Business Wire - ECNext

Forest Laboratories Inc.  -  Jun 19, 2006
Campral for alcohol addiction; Combunox for the short-term management of acute moderate and severe. pain; Aero-chamber, a device used to improve the ... $35.00 - Stock Reports - Standard & Poor's

No respite: for medical/surgical journals, the first half of 2005 has...  -  Oct 1, 2005
Combunox, placed third. Lipitor edged up one spot to 4th following a 24 percent increase in ad outlays, while Vytorin finished fifth with a 2 percent share ... $9.94 - Medical Marketing & Media - Alacra Store

Factiva Search  -  Mar 22, 2005
Forest Laboratories has launched its Combunox tablets for the short-term treatment of acute, moderate to severe pain, ... (c) 2005 Datamonitor plc. ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones

Factiva Search  -  Apr 18, 2005
2005 APR 18 - (NewsRx.com) -- Forest Laboratories, Inc., (FRX) announced that COMBUNOX (Oxycodone HCl and ibuprofen) ... © Copyright 2005 Pharma Business ... Pay-Per-View - Pharma Business Week - Factiva, from Dow Jones

Merger and Acquisition Scenario  -  May 13, 2006
The Company's products include Lexapro, Celexa, Namenda, Benicar, Campral, Combunox, RGH-188, GRC 3886, Desmoteplase, CCR1 Antagonists, Milnacipran, ... $250.00 - Revere Reports - Revere

The age of Alzheimer's: while a cure for Alzheimer's disease seems …  -  Aug 1, 2006
Medical Marketing & Media; April 1, 2007 ; 700+ words ... ... dropped from 2nd to 4th following a reduction in ad outlays for Namenda, Campral and Combunox ... Pay-Per-View - Medical Marketing & Media - HighBeam Research

Merger and Acquisition Scenario  -  Apr 15, 2006
The Company's products include Lexapro, Celexa, Namenda, Benicar, Campral, Combunox, RGH-188, GRC 3886, Desmoteplase, CCR1 Antagonists, Milnacipran, ... $250.00 - Revere Reports - Revere

Pharmaceutical: top 50 packages.(TOP 200 PACKAGERS)(Illustration) | …  -  Jul 1, 2005
22Forest Laboratories Inc. Benicar; Campral; (23) New York, N.Y. Combunox; Celexa; Lexapro; Namenda 23Hospira Inc. Carpuject; First Choice; Lake Forest, III ... Pay-Per-View - Food & Drug Packaging - HighBeam Research

Pharmaceutical: top 50 packages.(TOP 200 PACKAGERS)(Illustration)  -  Jul 1, 2005
22 Forest Laboratories Inc. Benicar; Campral; (23) New York, N.Y. Combunox; Celexa; Lexapro; Namenda 23 Hospira Inc. Carpuject; First Choice; Lake Forest, ... $4.95 - Food & Drug Packaging - ECNext

Minnesota - Official Notices - Department of Human Services  -  Jan 3, 2006
Combunox Narcotic opiate replacement agents Subutex Suboxone Non narcotic stimulants Provigil Triptans Quantities >18 tablets and nasal ... Pay-Per-View - RegAlert - Factiva, from Dow Jones

Article: Expert favors proven agents over peptide cosmeceuticals.( …  -  Mar 1, 2008
Article: New COMBUNOX(TM) (Oxycodone HCl and Ibuprofen) Tablets (CII) Now ... PR Newswire; March 21, 2005 ; 700+ words ... ... of oxycodone and ibuprofen, ... Pay-Per-View - Skin & Allergy News - HighBeam Research

Press Release: Barr Confirms Patent Challenge of Amrix(R) Extended- …  -  Nov 26, 2008
Article: Barr Receives Approval for Generic Combunox(R) Tablets, ... PR Newswire; November 29, 2007 ; 700+ words ... ... PRNewswire-FirstCall/ -- Barr ... Pay-Per-View - PR Newswire - HighBeam Research

Brand Names/Synonyms:
Combunox is also known by the following brand names and/or synonymsCodeinone, Dihydrohydroxy-; Combunox; Dea No. 9143; Dihydrohydroxycodeinone; Dihydrohydroxycondeinone; Dihydrone; Dihydroxycodeinone; Dinarkon; Diphydrone; ENDOCET; ENDODAN; Endone; Eubine; Eubine [France]; Eucodal; Eucodalum; Eukodal; Eutagen; HSDB 3142; Ossicodone [Dcit]; Oxanest; Oxicodona [Inn-Spanish]; Oxicon; Oxicone; Oxikon; Oxycet; Oxycodeinone; Oxycodon; Oxycodone; Oxycodone Hcl; Oxycodone Hydrochloride; Oxycodone [Usan:Ban:Inn]; Oxycodonum [Inn-Latin]; Oxycon; Oxycontin; PERCOCET; Pancodine; Percobarb; Percocet; Percodan; Roxicet; Roxicodone; Roxilox; Supendol [Canada]; Tecodin; Tekodin; Thecodine; Thekodin; Tylox

Drug Category:
Combunox is categorized under the following by the FDA: Narcotics; Antitussives; Analgesics, Opioid; Opiate Agonists; ATC:N02AA05

Dosage Forms:
Tablet; Suppository

Absorption:
well absorbed from OxyContin® tablets with an oral bioavailability of 60% to 87%

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
4, 5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy